Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VORICONAZOLE
- A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis
- Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis
- Drug-Drug Interaction Study of Vesatolimod in Adults With HIV-1 Who Have Very Low or Undetectable Virus Levels
- Drug-Drug Interaction Study of Voriconazole With Clarithromycin.
- The Safety of Paxlovid in Hemodialysis Patients With Covid-19
- Comparative Study on Tolerance and Pharmacokinetics of Voriconazole for Injection in Healthy Subjects
- Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status
- A New Posaconazole Dosing Regimen for Paediatric Patients With Cystic Fibrosis and Aspergillus Infection
- Azole-echinocandin Combination Therapy for Invasive Aspergillosis
- Single Ascending Dose and Multiple Ascending Dose Study of Voriconazole Inhalation Powder in Healthy Adult Subjects
- Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies
- A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis
- DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Pharmacokinetic Profile of Voriconazole Inhalation Powder in Adult Subjects With Asthma
- Evaluate Bioequivalence of Voriconazole(200mg/Vial) .
- Interaction Study of Zanubrutinib With Moderate and Strong CYP3A Inhibitors in Participants With B-Cell Malignancies
- Prophylactic Anticoagulation for Catheter-related Thrombosis
- Effectiveness and Efficiency of a Voriconazole Preemptive Genotyping Strategy
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
- Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel
- Three Induction Treatments on Cryptococcal Meningitis
- Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole Therapy
- Topical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes Onychomycosis
- Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma
- Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With the Tablets Formulation and Evaluation of the Po
- A Study to Evaluate the Appropriateness of the Voriconazole Dosing Regimen
- CYP2C19 Genotype-Specific Dosing Plus TDM on Reaching Therapeutic Voriconazole Blood Levels
- Efavirenz for Patients With Alzheimer's Disease
- Study to Evaluate the Safety and Efficacy of the Coadministration of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
- Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy Volunteers
- Clinical Study of AK1820 (Isavuconazonium Sulfate) for the Treatment of Deep Mycosis
- Combination Treatment of 5% Natamycin and 1% Voriconazole in Fungal Keratitis
- Pharmacokinetics of Two Different Formulation of Voriconazole
- Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PM
- Mycotic Antimicrobial Localized Injection for Treatment of Corneal Ulcers
- Anti-mold Azole in the Prophylaxis for Invasive Fusariosis
- Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent
- Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
- Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers
- Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus
- Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults
- Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral Administration
- Interaction Study of Ibrutinib and Cytochrome P450 (CYP) 3A Inhibitors in Participants With B-cell Malignancy
- A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area
- Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
- Voriconazole for IPA in Chinese Patients With COPD
- MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
- Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- Assessing the Safety and Efficacy of MK-5592 (Posaconazole) in Japanese Participants With Fungal Infection (MK-5592-101)
- CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
- Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
- Dose-finding of Rivaroxaban in Hemodialysis
- Posaconazole as Salvage Therapy for Aspergillus Pulmonary Infection.
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Dose Escalation Study Investigating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of ASP2215 in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Development of Voriconazole Pharmacokinetics and Metabolism in Children and Adolescents
- Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host Disease
- Individualisation of Voriconazole Antifungal Therapy Antifungal Therapy
- PEACE: Pediatric Antifungal Comparative Effectiveness
- Treatment of Newly Diagnosed Moderate or Severe Chronic Graft-versus-host Disease With Prednisone and Everolimus
- Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male Subjects
- A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069)
- Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot
- Short and Long-term Safety of Micafungin and Other Parenteral Antifungal Agents
- Voriconazole (Vfend) Special Investigation (Regulatory Post Marketing Commitment Plan)
- Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
- Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia
- ATCF (Azole Therapy in Cystic Fibrosis)
- Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence Therapy
- Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant
- Caspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal Infection
- Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g
- Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects
- A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard Dosing
- Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
- Population Pharmacokinetics of Anti-infectious Drugs in Children
- Evaluation of Antifungal Prophylaxis on Graft-versus-host Disease (GVHD) Patients
- Pharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal Disease
- Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive Aspergillosis
- Voriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric Subjects
- Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
- Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy
- Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
- Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy Volunteers
- Study of Cyclodextrin (SBECD) and Voriconazole Blood Concentrations During Continuous Dialysis
- A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
- Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of Voriconazole
- Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® Tablet In Korea
- Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IV
- Targeted, Dose-Escalation Busulfan-Etoposide as Prep Regimen
- Pharmacokinetics of Voriconazole in Obese Subjects
- The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs Placebo
- Mycotic Ulcer Treatment Trial I
- Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of Voriconazole
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy Subjects
- Pharmacokinetics of Posaconazole Prophylaxis in Acute Leukemia
- Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis
- Pharmacologic Optimization of Voriconazole
- Therapeutic Drug Monitoring of Voriconazole
- A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults
- A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In Children
- Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy Participants
- Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
- TMC125-TiDP2-C187: A Phase I, Open-label Trial to Investigate the Pharmacokinetic Interaction Between TMC125 and Two Antifungal Agents (Fluconazole and Voriconazole), All at Steady-state in Healthy Subjects.
- Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection
- A Study Of Indian Patients Receiving Therapy For Systemic Fungal Infections
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
- A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal Infections
- Antifungal Prophylaxis in Pediatric Acute Leukemia
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)
- Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal Ulcer
- A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised Adolescents
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
- Anidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive Aspergillosis
- Voriconazole as Prophylactic Therapy in Lung Transplant Recipients
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive Aspergillosis
- Ambisome and Management of Culture-negative Neutropenic Fever Unresponsive to Antibiotics
- Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal Infections
- Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida Infections
- Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis
- Antifungal Use in Oncohematological Neutropenic Patients
- A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity
- TBI Dose De-escalation for Fanconi Anemia
- To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days
- Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)
- A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections
- Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems
- Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
- A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
- Voriconazole For Chronic Bronchopulmonary Aspergillosis
- Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous Leukemia
- Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic Patients
- An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With Vfend
- Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants
- Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance Spectroscopy
- Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)
- Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy
- Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections
- Blood and Marrow Transplant Clinical Research Network
- Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal Infections
- Voriconazole to Prevent Systemic Fungal Infections in Children
- Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis
- Voriconazole to Treat Fungal Infections
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal Infections
- Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
Clinical trials list
click for details